Clinical Trial Update: Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of YY1201 for osteoarthritis of the knee has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• YY1201

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: WITHDRAWN